Singapore Pharmaceuticals and Healthcare Report Q2 2016

Date: March 16, 2016
Pages: 106
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SEE9BCE79CFEN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Non-communicable disease will continue to dominate Singapore's epidemiological profile, creating strong commercial opportunities for medicines addressing these illnesses. Companies seeking to benefit from these revenue earning prospects will have to compete with the population's ongoing use of alternative treatments as a supplement to conventional medicine.

Headline Expenditure Projections
  • Pharmaceuticals: SGD1.10bn (USD798mn) in 2015 to SGD1.15bn (USD790mn) by 2016; +5.1% in local currency terms and -0.9% in USD terms.
  • Healthcare: SGD19.67bn (USD14.31bn) in 2015 to SGD21.15bn (USD14.50bn) by 2016; +7.5% in local currency terms and 1.3% in USD terms.
BMI Industry View
  Table: Headline Pharmaceuticals & Healthcare Forecasts (Singapore 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Singapore 2012-2020)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Singapore 2012-2020)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Singapore 2012-2020)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Singapore 2012-2020)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Singapore 2012-2020)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Singapore 2012-2020)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Singapore 2012-2020)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Singapore 2012-2020)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Singapore 2014-2020)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Singapore 2014-2020)
Industry Risk/Reward Index
Asia Pacific Risk/Reward Index
Singapore Risk/Reward Index
Rewards
Risks
Regulatory Review
  Table: Regulatory Process Time Taken Under The CECA And Under The Abridged GDA
Intellectual Property Issues
Pricing And Reimbursement Regime
Market Overview
Healthcare Sector
  Table: Health Funding Sources In Singapore (SGDmn)
  Table: Healthcare Resources (Singapore 2010-2015)
  Table: Healthcare Activity (Singapore 2010-2015)
  Table: Healthcare Personnel (Singapore 2010-2015)
Research & Development
Clinical Trials
Epidemiology
  Table: Estimated Number Of New Cases Of Cancer In Singapore
Competitive Landscape
Research-Based Industry
  Table: Multinational Pharmaceutical Firm Presence In Singapore
  Table: Multinational Market Activity
  Table: Leading Generic Drugmakers In Singapore
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Baxter
GlaxoSmithKline
Haw Par
Merck & Co
MerLion
Novartis
Pfizer
Sanofi
Sci Gen
Demographic Forecast
Demographic Outlook
  Table: Population Headline Indicators (Singapore 1990-2025)
  Table: Key Population Ratios (Singapore 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Singapore 1990-2025)
  Table: Population By Age Group (Singapore 1990-2025)
  Table: Population By Age Group % (Singapore 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Ask Your Question

Singapore Pharmaceuticals and Healthcare Report Q2 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: